VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer
187,133MODERNA
33,878JANSSEN
2,321PFIZER\BIONTECH
1,091GLAXOSMITHKLINE BIOLOGICALS
983UNKNOWN MANUFACTURER
363MERCK & CO. INC.
229SEQIRUS, INC.
45DYNAVAX TECHNOLOGIES CORPORATION
41NOVARTIS VACCINES AND DIAGNOSTICS
29SANOFI PASTEUR
18EMERGENT BIOSOLUTIONS
8PAXVAX
7TEVA PHARMACEUTICALS
4PFIZER\WYETH
3BERNA BIOTECH, LTD.
2SMITHKLINE BEECHAM
2INTERCELL AG
2PROTEIN SCIENCES CORPORATION
1CSL LIMITED

Incidents per State

State Total
77,548
AK1,869
AL5,581
AR3,688
AS47
AZ14,288
CA61,984
CO11,665
CT8,149
DC1,663
DE1,807
FL37,749
FM5
GA15,058
GU120
HI2,453
IA4,625
ID2,692
IL20,334
IN24,007
KS4,615
KY7,696
LA4,887
MA14,654
MD12,514
ME3,129
MH11
MI18,739
MN12,528
MO9,710
MP29
MS2,790
MT2,375
NC16,368
ND1,356
NE2,880
NH3,100
NJ17,634
NM3,916
NV4,239
NY34,355
OH19,081
OK6,195
OR8,636
PA23,083
PR2,370
QM2
RI2,088
SC6,411
SD1,212
TN9,131
TX35,174
UT4,273
VA14,937
VI64
VT1,676
WA14,909
WI11,259
WV2,388
WY861
XB5
XL1
XV2

ID: 1240644
Sex: M
Age:
State: KY

Vax Date:
Onset Date:
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: ARM PAIN; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: UNKNOWN) dose was not reported, administered on 02-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced arm pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from arm pain. This report was non-serious.

Other Meds:

Current Illness:

ID: 1240645
Sex: F
Age:
State: MA

Vax Date:
Onset Date: 04/10/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: SWELLING OF THE FACE; This spontaneous report received from a consumer concerned a 68 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 10-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 10-APR-2021, the subject experienced swelling of the face. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from swelling of the face. This report was non-serious.

Other Meds:

Current Illness:

ID: 1240646
Sex: F
Age:
State: FL

Vax Date:
Onset Date: 03/31/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: BLURRED VISION; DOUBLE VISION; This spontaneous report received from a patient concerned a 52 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029 and expiry: 25/MAY/2021) dose was not reported, administered on 27-MAR-2021 09:30 for prophylactic vaccination. No concomitant medications were reported. On 31-MAR-2021, the subject experienced blurred vision. On 31-MAR-2021, the subject experienced double vision. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from blurred vision, and double vision. This report was non-serious.

Other Meds:

Current Illness:

ID: 1240647
Sex: F
Age:
State: VA

Vax Date:
Onset Date: 04/02/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: HEART PALPITATIONS; FOOT SWOLLEN; DIZZY SPELLS; MIGRAINE; PAIN RADIATED TO HEAD AND SIDE OF EAR AND SOMETIMES INTO FINGERS; REDNESS ON FOOT; TINGLING ON FOOT; FOOT NUMBNESS; UNABLE TO LIFT ARM; PAIN IN ARM; FEVER; HEADACHE; This spontaneous report received from a patient via a company representative concerned a 51 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included high blood pressure, autoimmune disorder, and neuropathy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A expiry: 29-JAN-2023) dose was not reported, administered on 02-APR-2021 12:30 to Right Arm for prophylactic vaccination. No concomitant medications were reported. On 02-APR-2021, the subject experienced heart palpitations. On 02-APR-2021, the subject experienced foot swollen. On 02-APR-2021, the subject experienced dizzy spells. On 02-APR-2021, the subject experienced migraine. On 02-APR-2021, the subject experienced pain radiated to head and side of ear and sometimes into fingers. On 02-APR-2021, the subject experienced redness on foot. On 02-APR-2021, the subject experienced tingling on foot. On 02-APR-2021, the subject experienced foot numbness. On 02-APR-2021, the subject experienced unable to lift arm. On 02-APR-2021, the subject experienced pain in arm. On 02-APR-2021, the subject experienced fever. On 02-APR-2021, the subject experienced headache. Treatment medications (dates unspecified) included: oxycodone/paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pain in arm, headache, heart palpitations, foot swollen, dizzy spells, fever, migraine, pain radiated to head and side of ear and sometimes into fingers, unable to lift arm, redness on foot, foot numbness, and tingling on foot. This report was non-serious.

Other Meds:

Current Illness: Autoimmune disorder; Blood pressure high; Neuropathy

ID: 1240648
Sex: U
Age:
State: TX

Vax Date:
Onset Date: 04/10/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: FAINTING SPELLS/ SYNCOPE; DIZZINESS/ LIGHTHEADEDNESS; NAUSEA; This spontaneous report received from a health care professional concerned multiple patients of unspecified age and sex. The patients' heights and weights were not reported. The patients had no known drug allergies. The patients received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 201A21A, expiry: Unknown) frequency one total, dose was not reported, administered on 10-APR-2021 in left arm for prophylactic vaccination. No concomitant medications were reported. The reporter stated that, on 10-APR-2021, the patients experienced side effects which included fainting spells/syncope, dizziness/lightheadedness and nausea within 15 minutes or so after vaccination at a mass vaccination clinic. The events were reported as serious by the reporter. The patients visited a healthcare professional office for fainting spells/syncope, dizziness/lightheadedness and nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fainting spells/syncope, dizziness/lightheadedness and nausea were not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: v0 This spontaneous report from a health care professional concerns multiple adult patients of unspecified age and gender from a mass vaccination site who experienced fainting spells/syncope, dizziness/lightheadedness and nausea within 15 minutes or so after the Janssen COVID-19 Vaccine Ad26.COV2 had been administered. Given the close temporal relationship and the nature of the events, the events are considered possibly related to the vaccination.

Other Meds:

Current Illness:

ID: 1240649
Sex: F
Age:
State: WA

Vax Date:
Onset Date: 04/07/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: SEVERE HEADACHE PAIN 5/10 ON A PAIN SCALE; FEVER 100.9 F; LIGHT SENSITIVITY; CHILLS; BODY ACHES; INTERMITTENT DULL SHOOTING PAIN TO BOTH LEGS; This spontaneous report received from a patient concerned a 38 year old female. The patient's weight was 162 pounds, and height was 65 inches. The patient's concurrent conditions included non alcoholic, and non smoker, and other pre-existing medical conditions included no known allergies and no drug abuse. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular and batch number: 202A21A expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 07-APR-2021, the subject experienced intermittent dull shooting pain to both legs. On 08-APR-2021, the subject experienced light sensitivity. On 08-APR-2021, the subject experienced chills. On 08-APR-2021, the subject experienced body aches. On 08-APR-2021, the subject experienced fever 100.9 f. On 09-APR-2021, the subject experienced severe headache pain 5/10 on a pain scale. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from light sensitivity on 09-APR-2021, and chills, body aches, and fever 100.9 f on 08-APR-2021, and had not recovered from severe headache pain 5/10 on a pain scale, and intermittent dull shooting pain to both legs. This report was non-serious.

Other Meds:

Current Illness:

ID: 1240650
Sex: F
Age:
State: MI

Vax Date:
Onset Date: 04/11/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: SWEATING; FELT VERY SICK; LEG SORENESS; SEVERE HEADACHE; FEELING HOT; TINGLING IN RIGHT ARM/LEGS; This spontaneous report received from a patient concerned a 51 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A, and expiry: 21-JUN-2021) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 11-APR-2021, the subject experienced tingling in right arm/legs. On 12-APR-2021, the subject experienced feeling hot. On 12-APR-2021, the subject experienced sweating. On 12-APR-2021, the subject experienced felt very sick. On 12-APR-2021, the subject experienced leg soreness. On 12-APR-2021, the subject experienced severe headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from feeling hot, sweating, felt very sick, leg soreness, and severe headache on 12-APR-2021, and tingling in right arm/legs on 11-APR-2021. This report was non-serious.

Other Meds:

Current Illness:

ID: 1240651
Sex: M
Age:
State: TN

Vax Date:
Onset Date: 03/21/2021
Rec V Date: 04/22/2021
Hospital: Y

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: GUILLAIN BARRE SYNDROME; This spontaneous report received from a consumer concerned a 62 year old male. The patient's height, and weight were not reported. The patient's concurrent medical history included diabetes. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805025, and expiry: 25-MAY-2021) dose was not reported, administered on 12-MAR-2021 for prophylactic vaccination. Concomitant medications included insulin for diabetes. The patient was in Critical Care unit. On Saturday, the next day after the vaccine, the patient was not felling well in afternoon and had laid down for few hours. They had a trip scheduled for Sunday. The patient was feeling well when he left home on Sunday. By Friday, 19-MAR-2021 (a week from the day he got his vaccine), he started with leg and knee pain. On 20-MAR-2021, the pain moved up to his back and then into his shoulders. The patient arrived home on Friday, 19-MAR-2021 and at 9:30 pm that night the patient woke up and could not handle the severe pain. On 20-MAR-2021, the patient was admitted to emergency room to ensure it was not heart related. The patient had a spinal trap on Saturday and by Sunday/Monday the patient found out it was Guillain barre syndrome. The patient was not able to walk and had also lost feeling from the neck down and could not move. The reporter had stated, the patient's right side was worse then left so doctors had investigated occurrence of stroke but nothing was found. The patient had episodes where he was unable to speak but was feeling better. He could talk and communicate better, but was limited and could not write. The doctors were working on getting the patient strong enough for rehab. The patient wife had stated that the recovery expected to be a long process. The patient wife also stated that patient was not on ventilator. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from Guillain barre syndrome. This report was serious (Hospitalization Caused / Prolonged, Life Threatening, and Disability Or Permanent Damage).; Sender's Comments: V0: A 62-year-old white male experienced Guillain-Barre Syndrome (GBS) 8 or 9 days after vaccine. Medical history included diabetes, for which he took insulin. On day 7 after vaccine, he started with leg and knee pain. On day 8, the pain moved up to his back and then into his shoulders, that night the patient was troubled by worsening pain and presented to emergency room. The patient had a spinal tap that day and within 1-2 days the patient found out it was GBS. The patient was not able to walk and had also lost feeling from the neck down and could not move. The patient's right side was worse than left so doctors had investigated occurrence of stroke but nothing was found. The patient had episodes where he was unable to speak but was feeling better. He could talk and communicate better but was limited and could not write. The doctors were working on getting the patient strong enough for rehab. The patient was not on a ventilator and a long recovery was anticipated. No laboratory results were reported, including those of campylobacter, viral infections, or cerebrospinal fluid analysis. Although there is a close temporal relationship, there is insufficient information to make a meaningful medical assessment. Additional information has been requested, including consent to contact the treating physicians to obtain additional details of clinical care and diagnostics.

Other Meds: Insulin

Current Illness: Diabetes (Only takes insulin.)

ID: 1240652
Sex: F
Age:
State: NE

Vax Date:
Onset Date: 04/12/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: BODY ACHE; NAUSEA; CHILLS; VOMITING; HOT FLASHES; MIGRAINE; This spontaneous report received from a patient concerned a 19 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included non alcohol user, and non smoker, and other pre-existing medical conditions included the patient had no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808982, and expiry: UNKNOWN) dose was not reported, administered on 12-APR-2021 13:00 for prophylactic vaccination. No concomitant medications were reported. On 12-APR-2021, the subject experienced vomiting. On 12-APR-2021, the subject experienced hot flashes. On 12-APR-2021, the subject experienced migraine. On 12-APR-2021, the subject experienced chills. On 12-APR-2021 18:00, the subject experienced nausea. On 13-APR-2021, the subject experienced body ache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from nausea, and the outcome of vomiting, hot flashes, body ache, chills and migraine was not reported. This report was non-serious.

Other Meds:

Current Illness: Abstains from alcohol; Non-smoker

ID: 1240653
Sex: F
Age:
State:

Vax Date:
Onset Date: 04/01/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: BODY ACHES; HEADACHE; FATIGUE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. No concomitant medications were reported. On APR-2021, the subject experienced body aches. On APR-2021, the subject experienced headache. On APR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache on APR-2021, and had not recovered from fatigue, and body aches. This report was non-serious.

Other Meds:

Current Illness:

ID: 1240654
Sex: F
Age:
State: NY

Vax Date:
Onset Date: 04/09/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: DIZZY; CHILLS; TIRED; NAUSEA; INJECTION SITE PAIN; This spontaneous report received from a patient concerned a 53 year old female. The patient's height, and weight were not reported. The patient's past medical history included genetic blood clot history, supraventricular tachycardia, and covid-19 infection, and concurrent conditions included penicillin allergy, non alcoholic, and non smoker. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980, and expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 12:00 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the patient experienced dizzy, chills, tired, nausea, injection site pain. Patient took Tylenol for chills and Pepcid for nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills on 10-APR-2021, was recovering from tired, dizzy, and nausea, and had not recovered from injection site pain. This report was non-serious.

Other Meds:

Current Illness: Abstains from alcohol; Non-smoker; Penicillin allergy

ID: 1240655
Sex: F
Age:
State: NC

Vax Date:
Onset Date: 04/01/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: BILATERAL UNDERARM LYMPH NODE SWELLING; TIREDNESS; INJECTION SITE SWELLING; This spontaneous report received from a patient concerned a 69 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included asthma, penicillin allergy, non alcohol user, and non smoker. The patient was not pregnant at the time of reporting. The patient had no drug abuse or illicit drug usage. The patient experienced drug allergy when treated with clarithromycin, and levofloxacin for drug used for unknown indication. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A21A, expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced injection site swelling. On 10-APR-2021, the subject experienced tiredness. On 11-APR-2021, the subject experienced bilateral underarm lymph node swelling. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from tiredness, and injection site swelling, and had not recovered from bilateral underarm lymph node swelling. This report was non-serious.

Other Meds:

Current Illness: Abstains from alcohol; Asthma; Non-smoker; Penicillin allergy

ID: 1240656
Sex: F
Age:
State: IN

Vax Date:
Onset Date: 04/07/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: MUSCLE SPASMS; STIFF NECK; TIGHTNESS IN THROAT; MUSCLE TWITCHES; HEAVINESS IN LIMBS; LOW GRADE FEVER; ARM PAIN; INJECTION SITE PAIN; This spontaneous report received from a patient concerned a 62 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, and expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 07-APR-2021, the subject experienced arm pain. On 07-APR-2021, the subject experienced injection site pain. On 08-APR-2021, the subject experienced stiff neck. On 08-APR-2021, the subject experienced tightness in throat. On 08-APR-2021, the subject experienced muscle twitches. On 08-APR-2021, the subject experienced heaviness in limbs. On 08-APR-2021, the subject experienced low grade fever. On 12-APR-2021, the subject experienced muscle spasms. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from stiff neck, and heaviness in limbs on 10-APR-2021, had not recovered from low grade fever, injection site pain, muscle spasms, arm pain, and muscle twitches, and the outcome of tightness in throat was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1240657
Sex: U
Age:
State: TX

Vax Date:
Onset Date: 04/12/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: SWELLING IN CHIN AREA WHICH MOVED ABOVE THE EYE; ITCHING; FATIGUE; This spontaneous report received from a consumer concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: Unknown) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested No concomitant medications were reported. On 12-APR-2021, the subject experienced swelling in chin area which moved above the eye. On 12-APR-2021, the subject experienced itching. On 12-APR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from itching, and had not recovered from swelling in chin area which moved above the eye, and fatigue. This report was non-serious.; Sender's Comments: V0: Medical assessment comments not required as per standard procedure as the case is assessed non serious.

Other Meds:

Current Illness:

ID: 1240658
Sex: F
Age:
State: FL

Vax Date:
Onset Date:
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: NUMBNESS IN HAND; LEG PAIN; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced numbness in hand, and leg pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the numbness in hand and leg pain was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1240659
Sex: F
Age:
State: LA

Vax Date:
Onset Date: 04/02/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: RASH; MUSCLE SORENESS; TIREDNESS; HEADACHE; This spontaneous report received from a patient concerned a 55 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included non smoker, and other pre-existing medical conditions included the patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, and expiry: UNKNOWN) dose was not reported, administered on 01-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 02-APR-2021, the subject experienced skin rash. On 02-APR-2021, the subject experienced muscle soreness. On 02-APR-2021, the subject experienced tiredness. On 02-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from skin rash, muscle soreness, tiredness, and headache on 03-APR-2021. This report was non-serious.

Other Meds:

Current Illness: Non-smoker

ID: 1240660
Sex: F
Age:
State: MN

Vax Date:
Onset Date: 04/12/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: PAIN IN LEGS; CHILLS; This spontaneous report received from a patient via a company representative concerned a 42 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 12-APR-2021, the subject experienced pain in legs. On 12-APR-2021, the subject experienced chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the pain in legs and chills was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1240661
Sex: F
Age:
State: MI

Vax Date:
Onset Date: 04/01/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: ARM SORE; BODY ACHES; CHILLS; BAD HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced arm sore. On APR-2021, the subject experienced body aches. On APR-2021, the subject experienced chills. On APR-2021, the subject experienced bad headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the bad headache, arm sore, body aches and chills was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1240662
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 04/22/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: MILD BODY PAIN / SORENESS; CHILLS; FEVER; MILD HEADACHE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced mild body pain, soreness, chills, fever, and mild headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the mild headache, mild body pain, fever, chills and soreness was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1240663
Sex: F
Age:
State:

Vax Date:
Onset Date: 04/01/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: LIGHTHEADED; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced lightheaded. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from lightheaded. This report was non-serious.

Other Meds:

Current Illness:

ID: 1240664
Sex: M
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: TESTICULAR SWELLING; TESTICULAR PAIN; FEVER; This spontaneous report received from a parent concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 2021, the subject experienced testicular swelling. On 2021, the subject experienced testicular pain. On 2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 102.3 Unit not reported. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, testicular swelling, and testicular pain. This report was non-serious.

Other Meds:

Current Illness:

ID: 1240665
Sex: F
Age:
State: AZ

Vax Date:
Onset Date: 04/01/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: HEADACHE; FELT TIRED; MUSCLE PAIN; NAUSEA; WHOLE BODY HURT; URGENCY TO POOP; JOINT PAIN AND HURTING IN KNEES; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, and expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced whole body hurt. On APR-2021, the subject experienced urgency to poop. On APR-2021, the subject experienced joint pain and hurting in knees. On APR-2021, the subject experienced felt tired. On APR-2021, the subject experienced muscle pain. On APR-2021, the subject experienced nausea. On 08-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from muscle pain, joint pain and hurting in knees, and whole body hurt, and the outcome of headache, felt tired, nausea and urgency to poop was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1240666
Sex: F
Age:
State: OK

Vax Date:
Onset Date: 04/09/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: BODY ACHES; FACIAL REDNESS; LOW GRADE FEVER; MILD HEADACHE; FATIGUE; This spontaneous report received from a patient concerned a 78 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 09-APR-2021, the subject experienced body aches. On 09-APR-2021, the subject experienced facial redness. On 09-APR-2021, the subject experienced low grade fever. On 09-APR-2021, the subject experienced mild headache. On 09-APR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches on 09-APR-2021, and facial redness, low grade fever, and mild headache on 12-APR-2021, and had not recovered from fatigue. This report was non-serious.

Other Meds:

Current Illness:

ID: 1240667
Sex: F
Age:
State: NY

Vax Date:
Onset Date: 04/12/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: RASH ON THE ARM; HEADACHE; CHARLIE HORSE FROM ARM TO BACK OF HEAD, BEHIND RIGHT EAR; This spontaneous report received from a patient concerned a 38 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, expiry: UNKNOWN) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-APR-2021, the subject experienced charlie horse from arm to back of head, behind right ear. On 12-APR-2021, the subject experienced headache. On 13-APR-2021, the subject experienced rash on the arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from rash on the arm, charlie horse from arm to back of head, behind right ear, and headache. This report was non-serious. The suspected product quality complaint has been confirmed to be voided did not meet PQC criteria based on the PQC evaluation/investigation performed.

Other Meds:

Current Illness:

ID: 1240668
Sex: F
Age:
State: NJ

Vax Date:
Onset Date:
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: BAD HEADACHE; BLURRY VISION; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included asthma, antiphospholipid syndrome, and allergy, and other pre-existing medical conditions included family history of stroke and heart attack. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced bad headache, and blurry vision. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the bad headache and blurry vision was not reported. This report was non-serious.

Other Meds:

Current Illness: Allergy; Antiphospholipid syndrome; Asthma

ID: 1240669
Sex: F
Age:
State: MD

Vax Date:
Onset Date: 04/12/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: FELT TIRED; FLU-LIKE SYMPTOMS (CHILLS AND HEADACHE); SORE LEFT ARM; BOTH HANDS HURTING AS WELL; This spontaneous report received from a patient concerned a 65 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included smoker. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A expiry: 21-JUN-2021) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-APR-2021, the subject experienced flu-like symptoms (chills and headache). On 12-APR-2021, the subject experienced sore left arm. On 12-APR-2021, the subject experienced both hands hurting as well. On 13-APR-2021, the subject experienced felt tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from flu-like symptoms (chills and headache), sore left arm, and both hands hurting as well on 13-APR-2021, and felt tired on 14-APR-2021. This report was non-serious.

Other Meds:

Current Illness: Smoker

ID: 1240670
Sex: M
Age:
State: NC

Vax Date:
Onset Date: 04/13/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: SKIN BREAKDOWN (ON ARMS AND TORSO AREA AND LITTLE BIT REDNESS); LITTLE BIT OF REDNESS; This spontaneous report received from a patient concerned a 56 year old male. The patient's weight was 190 pounds, and height was 180 centimeters. The patient's concurrent conditions included alcohol user, and non smoker, and other pre-existing medical conditions included the patient had no known drug allergies, had no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 043A21A, and batch number: 043A21A expiry: UNKNOWN) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 13-APR-2021, the subject experienced skin breakdown (on arms and torso area and little bit redness). On 13-APR-2021, the subject experienced little bit of redness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from skin breakdown (on arms and torso area and little bit redness), and the outcome of little bit of redness was not reported. This report was non-serious.

Other Meds:

Current Illness: Alcohol use (Occasionally couple times a week.); Non-smoker

ID: 1240671
Sex: F
Age:
State: VT

Vax Date:
Onset Date: 04/10/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: LOSS OF ENERGY; TIRED; HEADACHE; DIFFICULTY SLEEPING; PAIN IN THE ARM; This spontaneous report received from a patient concerned a 73 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included mango allergy, and shellfish allergy. The patient experienced drug allergy when treated with cefaclor, and erythromycin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808982, and batch number: 1808982 expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. Concomitant medications included levothyroxine. On 10-APR-2021, the subject experienced difficulty sleeping. On 10-APR-2021, the subject experienced pain in the arm. On 10-APR-2021, the subject experienced tired. On 10-APR-2021, the subject experienced headache. On 11-APR-2021, the subject experienced loss of energy. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from difficulty sleeping on 11-APR-2021, and was recovering from pain in the arm, loss of energy, tired, and headache. This report was non-serious.

Other Meds: LEVOTHYROXINE

Current Illness: Fruit allergy; Shellfish allergy

ID: 1240672
Sex: F
Age:
State: CA

Vax Date:
Onset Date: 04/12/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: ITCHING ALL OVER WITHOUT A RASH; FEELING FEVERISH; HEADACHE; FEELING HOT LIKE A FEVER; BONE PAIN; This spontaneous report received from a patient concerned a 54 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included asthma, alcohol use, and non-smoker, and other pre-existing medical conditions included no known drug allergies. no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808982, expiry: 23-JUN-2021) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, Laboratory data included: COVID-19 (NR: not provided) Negative. On 12-APR-2021, the subject experienced feeling hot like a fever. On 12-APR-2021, the subject experienced bone pain. On 12-APR-2021, the subject experienced headache. On 13-APR-2021, the subject experienced itching all over without a rash. On 13-APR-2021, the subject experienced feeling feverish. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from feeling hot like a fever, bone pain, headache, itching all over without a rash, and feeling feverish. This report was non-serious.

Other Meds:

Current Illness:

ID: 1240673
Sex: F
Age:
State: CT

Vax Date:
Onset Date: 04/10/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: JOINT PAIN; LOW GRADE FEVER; This spontaneous report received from a patient concerned a 43 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included tachycardia, bactrim allergy, flagyl allergy, and keflex allergy, and other pre-existing medical conditions included bactrim, flagyl, keflex allergy, when taken hives occurs with one, and c. diff with hospitalization occurs with the other. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, and batch number: 202A21A expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. Concomitant medications included propranolol for tachycardia. On 10-APR-2021, the subject experienced joint pain. On 10-APR-2021, the subject experienced low grade fever. Treatment medications (dates unspecified) included: oxycodone/paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from joint pain, and low grade fever on 11-APR-2021. This report was non-serious.

Other Meds: PROPRANOLOL

Current Illness: Allergic reaction to antibiotics; Drug allergy; Tachycardia

ID: 1240674
Sex: F
Age:
State: PA

Vax Date:
Onset Date: 04/12/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: PALMS AND FEETS AND FACE OBSERVED SOME BLUISH PATCHES; LIGHT HEADED; RIGHT HAND NOTICED AT THE BASE OF INDEX FINGER'S KNUCKLE SOME DEEP RED AND BIG BLUE COLORED CIRCLE WHICH LOOKED LIKE A BRUISE; COULD NOT STAND UP; BOTH OF HANDS BACK SIDE BRIGHT RED COLORED; FELT CHILLS; HEADACHE; FEVER; NAUSEA; This spontaneous report received from a patient concerned a 56 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A expiry: UNKNOWN) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-APR-2021, the subject experienced palms and feets and face observed some bluish patches. On 12-APR-2021, the subject experienced light headed. On 12-APR-2021, the subject experienced right hand noticed at the base of index finger's knuckle some deep red and big blue colored circle which looked like a bruise. On 12-APR-2021, the subject experienced could not stand up. On 12-APR-2021, the subject experienced both of hands back side bright red colored. On 12-APR-2021, the subject experienced felt chills. On 12-APR-2021, the subject experienced headache. On 12-APR-2021, the subject experienced fever. On 12-APR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from right hand noticed at the base of index finger's knuckle some deep red and big blue colored circle which looked like a bruise on APR-2021, and the outcome of felt chills, palms and feets and face observed some bluish patches, headache, fever, nausea, light headed, could not stand up and both of hands back side bright red colored was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1240675
Sex: F
Age:
State: MN

Vax Date:
Onset Date: 04/01/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: POSSIBLE UNEXPECTED BENEFIT (DID NOT WAKE UP IN THE MIDDLE OF THE NIGHT WITH HEAVY SWEATING. PREVIOUSLY PATIENT WAS WAKING UP 2 TO 3 TIMES WITH SAME AND IT WAS REALLY BAD); This spontaneous report received from a patient concerned a 54 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included history of woke up in the middle of the night with heavy sweating. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: UNKNOWN) dose was not reported, administered on 03-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced possible unexpected benefit (did not wake up in the middle of the night with heavy sweating. previously subject was waking up 2 to 3 times with same and it was really bad). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of possible unexpected benefit (did not wake up in the middle of the night with heavy sweating. previously patient was waking up 2 to 3 times with same and it was really bad) was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1240676
Sex: M
Age:
State: NV

Vax Date:
Onset Date:
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: FLU-LIKE SYMPTOMS; This spontaneous report received from a patient concerned a 45 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 10-APR-2021 09:30 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced flu-like symptoms. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of flu-like symptoms was not reported. This report was non-serious. This case, from the same reporter is linked to 20210427236.

Other Meds:

Current Illness:

ID: 1240677
Sex: U
Age:
State:

Vax Date:
Onset Date: 04/01/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: BRUISE ON THE CALF MUSCLE; LUMPS ON THE CALF MUSCLE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On APR-2021, the subject experienced bruise on the calf muscle. On APR-2021, the subject experienced lumps on the calf muscle. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the bruise on the calf muscle and lumps on the calf muscle was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1240678
Sex: F
Age:
State: NV

Vax Date:
Onset Date: 04/01/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: NUMBNESS IN ARMS; FEELING OF PINS AND NEEDLES; HEARING CHANGE; FLU-LIKE SYMPTOMS; SORENESS ON TOP OF HEAD; This spontaneous report received from a consumer concerned a 37 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose was not reported, administered on 10-APR-2021 09:30 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced numbness in arms. On APR-2021, the subject experienced feeling of pins and needles. On APR-2021, the subject experienced hearing change. On APR-2021, the subject experienced flu-like symptoms. On APR-2021, the subject experienced soreness on top of head. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the numbness in arms, feeling of pins and needles, hearing change, flu-like symptoms and soreness on top of head was not reported. This report was non-serious. This case, from the same reporter is linked to 20210427206.

Other Meds:

Current Illness:

ID: 1240679
Sex: M
Age:
State: AK

Vax Date:
Onset Date: 03/26/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: STIFFNESS IN NECK; DULL ACHE IN NECK; FOCUS ISSUE; BODY ACHE; FEVER; FATIGUE/EXHAUSTION; INTERMITTENT HEADACHE; This spontaneous report received from a consumer concerned a 47 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included hydrocodone allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 26-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 26-MAR-2021, the subject experienced stiffness in neck. On 26-MAR-2021, the subject experienced dull ache in neck. On 26-MAR-2021, the subject experienced focus issue. On 26-MAR-2021, the subject experienced body ache. On 26-MAR-2021, the subject experienced fever. On 26-MAR-2021, the subject experienced fatigue/exhaustion. On 26-MAR-2021, the subject experienced intermittent headache. Laboratory data included: Body temperature (NR: not provided) 101. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body ache, and fever on 27-MAR-2021, and had not recovered from fatigue/exhaustion, intermittent headache, dull ache in neck, stiffness in neck, and focus issue. This report was non-serious.

Other Meds:

Current Illness: Drug allergy

ID: 1240680
Sex: F
Age:
State: LA

Vax Date:
Onset Date: 04/08/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: FLU LIKE SYMPTOMS; STOMACH DISCOMFORT; BODY ACHES; CHILLS; FEVER; NAUSEA; HEADACHE; TIRED; This spontaneous report received from a patient concerned a 62 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980,expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 08-APR-2021, the subject experienced flu like symptoms. On 08-APR-2021, the subject experienced stomach discomfort. On 08-APR-2021, the subject experienced body aches. On 08-APR-2021, the subject experienced chills. On 08-APR-2021, the subject experienced fever. On 08-APR-2021, the subject experienced nausea. On 08-APR-2021, the subject experienced headache. On 08-APR-2021, the subject experienced tired. On 13-APR-2021, treatment medications included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, nausea, flu like symptoms, headache, chills, stomach discomfort, and body aches, and the outcome of tired was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1240681
Sex: F
Age:
State: SD

Vax Date:
Onset Date:
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: SORE KNEE; SORE THUMB; This spontaneous report received from a patient concerned a 60 year old female. The patient's height, and weight were not reported. The patient's past medical history included breast cancer, mastectomy, chemotherapy, and radiation, and concurrent conditions included arthritis, cigarette smoker, abstains from alcohol, and chest tightness, and other pre-existing medical conditions included patient received injection for her arthritis in her back last month. The patient experienced drug allergy when treated with codeine, and paracetamol for drug used for unknown indication. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 12-APR-2021 18:30 for an unspecified indication. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced sore knee, and sore thumb. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from sore knee, and sore thumb. This report was non-serious.

Other Meds:

Current Illness: Abstains from alcohol; Arthritis (Patient received injection for her arthritis in her back last month); Chest tightness (using tylenol with codeine); Cigarette smoker (1 pack every 3 to 4 days)

ID: 1240682
Sex: F
Age:
State: FL

Vax Date:
Onset Date: 04/01/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: DIZZINESS; OUT OF REALITY; EARLY MENSTRUAL CYCLE WITH HEAVY FLOW; ARM PAIN; FATIGUE; NAUSEA; OVERALL WEAKNESS; This spontaneous report received from a patient concerned a 43 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202a21a, expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced dizziness. On APR-2021, the subject experienced out of reality. On APR-2021, the subject experienced early menstrual cycle with heavy flow. On APR-2021, the subject experienced arm pain. On APR-2021, the subject experienced fatigue. On APR-2021, the subject experienced nausea. On APR-2021, the subject experienced overall weakness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fatigue, and overall weakness, and the outcome of dizziness, arm pain, nausea, out of reality and early menstrual cycle with heavy flow was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1240683
Sex: F
Age:
State: CA

Vax Date:
Onset Date: 04/01/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: ABDOMINAL PAIN; LEG PAIN; HEADACHE; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on APR-2021 for prophylactic vaccination. The batch number was not provided and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced abdominal pain. On APR-2021, the subject experienced leg pain. On APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache, abdominal pain and leg pain was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1240684
Sex: F
Age:
State: TX

Vax Date:
Onset Date: 04/10/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: CONGESTION; FATIGUE; This spontaneous report received from a patient concerned a 48 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, and batch number: 201A21A expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 10-APR-2021, the subject experienced fatigue. On an unspecified date, the subject experienced congestion. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fatigue and congestion was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1240685
Sex: F
Age:
State: WI

Vax Date:
Onset Date: 04/11/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: BLURRED VISION FOR THREE DAYS; HEADACHE; TIREDNESS; This spontaneous report received from a patient concerned a 61 year old female. The patient's weight was 193 pounds, and height was 64 inches. The patient's concurrent conditions included seizure disorder, non-alcoholic, and non-smoker, and other pre-existing medical conditions included the patient had no known allergies. The patient had no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 11-APR-2021, the subject experienced blurred vision for three days. On 11-APR-2021, the subject experienced headache. On 11-APR-2021, the subject experienced tiredness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from blurred vision for three days on APR-2021, and headache, and tiredness on 12-APR-2021. This report was non-serious.

Other Meds:

Current Illness: Abstains from alcohol; Convulsive disorder; Non-smoker

ID: 1240686
Sex: F
Age:
State: CA

Vax Date:
Onset Date: 04/10/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: VOMITING; RATTLING COUGH; NOT SLEEPING; TEMPERATURE-FEEL FOREHEAD WARM; NAUSEA; This spontaneous report received from a patient concerned a 64 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808982, and batch number: 1808982 expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 10-APR-2021, the subject experienced vomiting. On 10-APR-2021, the subject experienced rattling cough. On 10-APR-2021, the subject experienced not sleeping. On 10-APR-2021, the subject experienced temperature-feel forehead warm. On 10-APR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from vomiting, rattling cough, not sleeping, nausea, and temperature-feel forehead warm. This report was non-serious.

Other Meds:

Current Illness:

ID: 1240687
Sex: F
Age:
State: CA

Vax Date:
Onset Date: 04/10/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: COLD SYMPTOMS; FEVER; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 10-APR-2021, the subject experienced cold symptoms. On 10-APR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from cold symptoms, and fever on 11-APR-2021. This report was non-serious.

Other Meds:

Current Illness:

ID: 1240688
Sex: M
Age:
State: NJ

Vax Date:
Onset Date: 04/09/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: HEADACHE; FATIGUE; NAUSEA; FEVER OF 102F; TERRIBLE MUSCLE ACHES; This spontaneous report received from a consumer concerned a 19 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 41A21A, and batch number: 41A21A expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021 18:30, the subject experienced headache. On 09-APR-2021 18:30, the subject experienced fatigue. On 09-APR-2021 18:30, the subject experienced nausea. On 09-APR-2021 18:30, the subject experienced fever of 102f. On 09-APR-2021 18:30, the subject experienced terrible muscle aches. Laboratory data included: Body temperature (NR: not provided) 102 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache, fatigue, nausea, fever of 102f, and terrible muscle aches on 11-APR-2021 09:00. This report was non-serious.

Other Meds:

Current Illness:

ID: 1240689
Sex: M
Age:
State: MA

Vax Date:
Onset Date:
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: HEADACHE; This spontaneous report received from a patient via a company representative concerned a 64 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included obesity. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 24-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 2021, the subject experienced headache. Treatment medications (dates unspecified) included: acetylsalicylic acid, and paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache on 2021. This report was non-serious.

Other Meds:

Current Illness: Obesity

ID: 1240690
Sex: F
Age:
State: TX

Vax Date:
Onset Date: 04/02/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: ANEMIA; INSOMNIA; BODY ACHES; CHILLS; ARM SORENESS; TINGLING IN TOES AND FINGERS; NUMBNESS IN TOES, KNEES & FINGERS; This spontaneous report received from a patient concerned a 41 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A, expiry: UNKNOWN) dose was not reported, administered on 02-APR-2021 13:30 for prophylactic vaccination. No concomitant medications were reported. On 02-APR-2021 16:30, the subject experienced tingling in toes and fingers. On 02-APR-2021 16:30, the subject experienced numbness in toes, knees & fingers. On 02-APR-2021 16:30, the subject experienced body aches. On 02-APR-2021 16:30, the subject experienced chills. On 02-APR-2021 16:30, the subject experienced arm soreness. On an unspecified date, the subject experienced anemia, and insomnia. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, and chills on 03-APR-2021, had not recovered from tingling in toes and fingers, numbness in toes, knees & fingers, and arm soreness, and the outcome of anemia and insomnia was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1240691
Sex: M
Age:
State: FL

Vax Date:
Onset Date: 04/14/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: FEELING WARMTH IN LEFT LEG/BOTH FEET/HANDS; This spontaneous report received from a patient concerned a 43 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 042A21A, expiry: UNKNOWN) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 14-APR-2021, the subject experienced feeling warmth in left leg/both feet/hands. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from feeling warmth in left leg/both feet/hands. This report was non-serious.

Other Meds:

Current Illness:

ID: 1240692
Sex: F
Age:
State: FL

Vax Date:
Onset Date: 04/08/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: DIARRHEA; SLIGHT FEVER; SLEEPING A LOT; SICKNESS; CHILLS; FEELING NOT WELL; NAUSEA; HEADACHE; This spontaneous report received from a consumer concerned a 91 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609, expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, Laboratory data included: COVID-19 PCR test (NR: not provided) Negative. On 08-APR-2021, the subject experienced sleeping a lot. On 08-APR-2021, the subject experienced sickness. On 08-APR-2021, the subject experienced chills. On 08-APR-2021, the subject experienced feeling not well. On 08-APR-2021, the subject experienced nausea. On 08-APR-2021, the subject experienced headache. On 09-APR-2021, the subject experienced slight fever. On 13-APR-2021, the subject experienced diarrhea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the nausea, headache, chills, feeling not well, diarrhea, slight fever, sleeping a lot and sickness was not reported. This report was non-serious. The suspected product quality complaint has been confirmed to be voided (did not meet pqc criteria) based on the PQC evaluation/investigation performed.

Other Meds:

Current Illness:

ID: 1240693
Sex: F
Age:
State: CA

Vax Date:
Onset Date: 04/12/2021
Rec V Date: 04/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: LIGHT PAIN; DIZZINESS; FATIGUE; NAUSEA; This spontaneous report received from a patient concerned a 43 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included non smoker, and abstains from alcohol, and other pre-existing medical conditions included no known allergies. no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, and expiry: UNKNOWN) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-APR-2021, the subject experienced light pain. On 12-APR-2021, the subject experienced dizziness. On 12-APR-2021, the subject experienced fatigue. On 12-APR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from light pain, fatigue, dizziness, and nausea. This report was non-serious.

Other Meds:

Current Illness: Abstains from alcohol; Non-smoker

Total 2021 VAERS Injuries: 636,615

Page last modified: 03 October 2021 5:28pm